“Efficacy and survival analysis of apatinib combined with capecitabine chemotherapy for second-line treatment of advanced esophageal cancer”, IJCT, vol. 29, no. 6, pp. 793–798, May 2023, doi: 10.56042/ijct.v29i6.67385.